Open an account

Sight Sciences

SGHT · NASDAQ

$8.62+$0.36 (+4.36%)TodayMarket closed ·
Prev close $8.26

About SGHT

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company is headquartered in Menlo Park, California and currently employs 186 full-time employees. The company went IPO on 2021-07-15. The firm is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The firm operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.

Employees
186
Headquarters
Menlo Park, California
Listed
Jul 15, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
sightsciences.com

SGHT key statistics

Market cap
474.86M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
345.94K
Volume
258.56K
Open price
$8.26
High today
$8.76
Low today
$8.09
52 Week high
$9.71
52 Week low
$3.38

Sight Sciences (SGHT) at a glance

As of Oct 20, 2026, Sight Sciences (SGHT) shares are priced at $8.62, giving the company a market cap of 474.86M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $8.09 and $8.76. The current price is 6.6% above the day's low and 1.5% below its high.

Volume so far is 258.56K shares, below the average of 345.94K shares a day.

Over the past year Sight Sciences has ranged from $3.38 to $9.71, and now sits 83% of the way up that range.

Sight Sciences met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.08 per share against an estimate of -$0.1573.

The average analyst price target is $9.01, 4.5% above the current price, from 8 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

75%of 8 analyst ratings say Buy
  • Buy75.0%
  • Hold25.0%
  • Sell0.0%
Price target · 8 analystsAvg $9.01
Low
$8.08
Now
$8.62
High
$12.60

SGHT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 29.6% on average.

  1. Q3 FY24: reported -$0.22 per share against an estimate of -$0.2117
  2. Q4 FY24: reported -$0.23 per share against an estimate of -$0.2076
  3. Q1 FY25: reported -$0.28 per share against an estimate of -$0.2879
  4. Q2 FY25: reported -$0.23 per share against an estimate of -$0.2687
  5. Q3 FY25: reported -$0.16 per share against an estimate of -$0.2573
  6. Q4 FY25: reported -$0.08 per share against an estimate of -$0.142
  7. Q1 FY26: reported -$0.24 per share against an estimate of -$0.1686
  8. Q2 FY26: reported -$0.08 per share against an estimate of -$0.1573

SGHT news

  • Vandana Singh

    Why Is Sight Sciences Stock Gaining Thursday?

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • Press releaseGlobe Newswire

    Sight Sciences Reports Second Quarter 2026 Financial Results

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

  • Press releaseGlobe Newswire

    Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

  • Press releaseGlobe Newswire

    Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

Similar companies

Companies in the same industry as Sight Sciences

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.